Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-1570 is under clinical development by Astellas Pharma and currently in Phase II for Non-Small Cell Lung Carcinoma. According to GlobalData, Phase II drugs for Non-Small Cell Lung Carcinoma have a 25% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. GlobalData’s report assesses how ASP-1570’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Clinical Trials 130

Clinical Trials Clinical Trials Drugs Clinical Development 130

Medical Xpress

FEBRUARY 25, 2023

Substance use disorder (SUD) is an extremely difficult disorder to overcome, and many individuals with SUD return to regular use after repeated attempts to quit.

136

136

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-1570 is under clinical development by Astellas Pharma and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 34% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. GlobalData’s report assesses how ASP-1570’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Clinical Trials 130

Clinical Trials Clinical Trials Drugs Clinical Development 130

Medical Xpress

FEBRUARY 25, 2023

The Food and Drug Administration on Friday approved the first combination test for flu and C OVID-19 that can be used at home, giving consumers an easy way to determine if a runny nose is caused by either disease.

Drugs 115

Drugs 115

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-1570 is under clinical development by Astellas Pharma and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 10% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. GlobalData’s report assesses how ASP-1570’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Clinical Trials 130

Clinical Trials Clinical Trials Drugs Clinical Development 130

Medical Xpress

FEBRUARY 25, 2023

A stroke left Heather Rendulic with little use of her left hand and arm, putting certain everyday tasks like tying shoes or cutting foods out of reach.

119

119

STAT News

FEBRUARY 25, 2023

Several leading advocacy groups are asking the U.S. Trade Representative not to sanction or pressure four countries — Brazil, Ukraine, South Africa, and India — if the governments grant requests from cystic fibrosis patients to sidestep or revoke patents on a pricey medicine. The move comes after the patients and their families last month took the unusual step of petitioning their governments due to ongoing frustration that they are unable to access a Vertex Pharmaceutical treatmen

Medicine 98

Medicine Drugs 98

Pharmaceutical Technology

FEBRUARY 25, 2023

BAY-2416964is under clinical development by Bayer and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer).

Clinical Development 130

Clinical Development Development 130

NPR Health - Shots

FEBRUARY 25, 2023

The at-home nasal swab kit simultaneously tests for COVID-19 and two strains of the flu.

128

128

Pharmaceutical Technology

FEBRUARY 25, 2023

C-106is under clinical development by Vicore Pharma and currently in Phase I for Idiopathic Pulmonary Fibrosis.

Clinical Development 130

Clinical Development Development 130

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Cloudbyz

FEBRUARY 25, 2023

Medical coding is a key component of pharmacovigilance, as it involves assigning standardized codes to medical terms in order to enable efficient data management and analysis. With the growing volume of pharmacovigilance data, automation of medical coding has become an attractive option Pharmacovigilance is the process of monitoring and assessing adverse drug reactions (ADRs) and other medication safety issues.

Compliance 86

Compliance Regulation Drugs Development 86

Pharmaceutical Technology

FEBRUARY 25, 2023

ATH-1020 is under clinical development by Athira Pharma and is currently in the Phase I in clinical pathway.

Clinical Development 130

Clinical Development Development 130

Drug Discovery World

FEBRUARY 25, 2023

Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting lab automation to decision-making How machine learning and lab automation are changing the future of protein therapeutics Harnessing the power of data science and AI in life sciences If you are attending the ev

Life Science 52

Life Science Protein Drugs 52

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-3082 is under clinical development by Astellas Pharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 54% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how ASP-3082’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Clinical Trials 100

Clinical Trials Clinical Trials Drugs Clinical Development 100

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Clinical Supply

NPR Health - Shots

FEBRUARY 25, 2023

The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?

Drugs 48

Drugs 48

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-3082 is under clinical development by Astellas Pharma and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase I drugs for Metastatic Colorectal Cancer have an 85% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how ASP-3082’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Clinical Trials 100

Clinical Trials Clinical Trials Drugs Clinical Development 100

Drug Patent Watch

FEBRUARY 25, 2023

This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Serbia? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs 98

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-2138 is under clinical development by Xencor and currently in Phase I for Metastatic Adenocarcinoma of The Pancreas. According to GlobalData, Phase I drugs for Metastatic Adenocarcinoma of The Pancreas have an 88% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how ASP-2138’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Antibody 100

Antibody Engineer Clinical Trials Clinical Trials 100

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Medical Xpress

FEBRUARY 25, 2023

The Biden administration moved Friday to require patients see a doctor in person before getting attention deficit disorder medication or addictive painkillers, toughening access to the drugs against the backdrop of a deepening opioid crisis.

Drugs 100

Drugs Doctors Doctor 100

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-2138 is under clinical development by Xencor and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I drugs for Gastric Cancer have a 79% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how ASP-2138’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Antibody 100

Antibody Engineer Clinical Trials Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 25, 2023

ASP-2138 is under clinical development by Xencor and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According to GlobalData, Phase I drugs for Adenocarcinoma Of The Gastroesophageal Junction have an 88% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how ASP-2138’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Antibody 100

Antibody Engineer Clinical Trials Clinical Trials 100